V3651 Pill - white capsule/oblong
Pill with imprint V3651 is White, Capsule/Oblong and has been identified as Fenofibrate 145 mg. It is supplied by AustarPharma, LLC.
Fenofibrate is used in the treatment of Hypertriglyceridemia; High Cholesterol; Hyperlipoproteinemia Type IIa, Elevated LDL; Hyperlipoproteinemia; Hyperlipoproteinemia Type IV, Elevated VLDL and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for V3651
Fenofibrate
- Imprint
- V3651
- Strength
- 145 mg
- Color
- White
- Shape
- Capsule/Oblong (film coated, modified capsule shape)
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AustarPharma, LLC
- National Drug Code (NDC)
- 35561-0250
See also:
More about fenofibrate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (71)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: fibric acid derivatives
- Breastfeeding
- En español
Patient resources
Other brands
TriCor, Lofibra, Triglide, Lipofen, ... +2 more
Professional resources
Other brands
TriCor, Lofibra, Triglide, Lipofen, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.